Dependence on Distributors and SoftBank
First written in FY2021. 3 of 5 entries say "Mitigated", first in FY2022. Latest entry: FY2025.
Science Arts moved to the "Worse" side of this theme in 2025, 3 years after the typical company in this theme (2022).
The whole theme swung hardest in 2017: 4 of 15 companies on the "Worse" side.
6 other companies' latest entry also says "Worsened".
- FY2025WorsenedAnnual report
「Sales to SoftBank Corp. were ¥338.460 million, accounting for 28.6% of total sales, compared with ¥641.580 million, or 38.8%, in the fiscal year.」
The ratio of sales to SoftBank Corp. rose from 28.6% in the previous fiscal year to 38.8%, increasing the figure indicating dependence on distributors and SoftBank Corp. for sales. - FY2024MitigatedAnnual report
「Sales to SoftBank Corp. were ¥235.757 million, accounting for 30.5% of total sales, compared with ¥338.460 million, or 28.6%, in the fiscal year.」
The ratio of sales to SoftBank Corp. declined from 30.5% to 28.6%. At the same time, the policy of using distributors and the associated dependence risk continue. - FY2023MitigatedAnnual report
「Sales to SoftBank Corp. were ¥213.121 million, accounting for 32.3% of total sales.」
Sales to SoftBank Corp. in the fiscal year were ¥235.757 million, accounting for 30.5% of total sales, down from 32.3%. The company continues to disclose the risk of dependence on distributors. - FY2022MitigatedAnnual report
「Sales to SoftBank Corp. were ¥213.121 million, accounting for 32.3% of total sales.」
The ratio of sales to SoftBank Corp. declined from 37.0% in the previous fiscal year to 32.3%, but the company continues to identify dependence on distributors and SoftBank Corp.'s sales trends as risks. - FY2021First statedAnnual report
「The company outsources most of its order-taking activities to distributors. In particular, the company's sales are highly dependent on SoftBank Corp., and its operating results may be affected by SoftBank Corp.'s sales trends.」
Sales to SoftBank Corp. in the fiscal year ended August 2021 were ¥135.403 million, or 37.0% of total sales.